New Enterprise Associates 16, L.P.

Insider Reports History

Location
Timonium, MD
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by New Enterprise Associates 16, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 2,186,243 $61,291,541 $28.04 13 Jun 2023 Direct
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 12,273,280 $16,814,393 $1.37 17 Apr 2025 Direct
Marker Therapeutics, Inc. 10%+ Owner Common Stock 1,625,678 $5,202,170 $3.20 23 Dec 2024 Direct
Metacrine, Inc. 10%+ Owner Common Stock 2,563,257 $1,204,731 $0.4700 22 Dec 2021 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 02 Oct 2025 Direct
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 30 Nov 2022 Direct
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 25 May 2022 Direct
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 02 Oct 2025 Direct
Trevi Therapeutics, Inc. 10%+ Owner 3.5-Year Common Stock Warrant 0 17 Apr 2025 Direct

Insider Reports Filed by New Enterprise Associates 16, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRVI Trevi Therapeutics, Inc. 31 Dec 2025 2 +$2,537,037 5 10%+ Owner 13 Feb 2026, 16:30
NEUE NeueHealth, Inc. 02 Oct 2025 8 +$5.25 4 Director, 10%+ Owner 06 Oct 2025, 17:48
MRKR Marker Therapeutics, Inc. 23 Dec 2024 1 +$1,773,600 4 10%+ Owner 23 Dec 2024, 16:40
NEUE NeueHealth, Inc. 01 Oct 2024 1 $0 4 10%+ Owner 03 Oct 2024, 18:12
NEUE NeueHealth, Inc. 08 Apr 2024 1 $0 4 10%+ Owner 10 Apr 2024, 18:41
MIRM Mirum Pharmaceuticals, Inc. 13 Jun 2023 1 $0 4 10%+ Owner 15 Jun 2023, 16:22
/report/000120919122059440-new-enterprise-associates-16-l-p-2022-11-30 Akouos, Inc. 30 Nov 2022 1 $0 4 10%+ Owner 02 Dec 2022, 16:01
/report/000120919122032327-new-enterprise-associates-16-l-p-2022-05-24 GENOCEA BIOSCIENCES, INC. 24 May 2022 2 -$750,662 4 10%+ Owner 26 May 2022, 18:26
TRVI Trevi Therapeutics, Inc. 11 Apr 2022 1 +$4,999,998 4 10%+ Owner 13 Apr 2022, 17:00
/report/000120919121071265-new-enterprise-associates-16-l-p-2021-12-10 Metacrine, Inc. 10 Dec 2021 3 -$494,483 4 10%+ Owner 27 Dec 2021, 15:40
TRVI Trevi Therapeutics, Inc. 18 Oct 2021 3 $0 4 10%+ Owner 19 Oct 2021, 21:09